Honghu Jiang, Lu Zhu, Lanting Yang, Hongyuan Ren, Yan Yu, Jingyin Zhu
{"title":"Photochemical Crosslinking as an Adjunct for Repairing Corneal Perforations in Rabbits.","authors":"Honghu Jiang, Lu Zhu, Lanting Yang, Hongyuan Ren, Yan Yu, Jingyin Zhu","doi":"10.1002/lsm.70068","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To assess the efficacy and tolerability of Rose Bengal-induced photochemical crosslinking (RB-PCL) as an adjunct to suturing for corneal perforation repair in rabbits.</p><p><strong>Methods: </strong>A 4.5 mm corneal wound was created in New Zealand White Rabbits (right eyes), followed by suturing and RB-PCL treatment using 532 nm green light (0.6 W/cm²) and 0.01% RB photosensitizer. A control group received sutures alone. Healing was evaluated at Weeks 1, 2, and 4 using slit-lamp biomicroscopy, anterior segment optical coherence tomography (AS-OCT), RT-PCR for α-SMA gene expression, and immunofluorescence for myofibroblast activation. Histopathological changes were assessed via Hematoxylin and Eosin (H&E) staining, and corneal endothelial cell counts were taken to assess cytotoxicity.</p><p><strong>Results: </strong>RB-PCL accelerated suture removal by Day 5, while sutures in the control group required longer retention. At Weeks 1 and 2, RB-PCL demonstrated lower inflammation and reduced corneal opacity. By Weeks 2 and 4, α-SMA expression was significantly reduced in the RB-PCL group, indicating reduced myofibroblast activation and fibrosis. H&E staining showed complete healing in the RB-PCL group by Week 2, whereas the control group had incomplete repair. By Week 4, the RB-PCL group had better fiber arrangement, while the control group showed persistent fibrosis. Immunofluorescence confirmed reduced α-SMA expression in the RB-PCL group. No retinal damage was observed, and endothelial cell counts were similar between groups, indicating RB-PCL's tolerability.</p><p><strong>Conclusions: </strong>RB-PCL improved corneal wound healing, reduced fibrosis and opacity, and allowed earlier suture removal without phototoxicity. These results suggest RB-PCL is a promising adjunct for corneal perforation repair, enhancing both efficacy and tolerability.</p>","PeriodicalId":17961,"journal":{"name":"Lasers in Surgery and Medicine","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lasers in Surgery and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/lsm.70068","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To assess the efficacy and tolerability of Rose Bengal-induced photochemical crosslinking (RB-PCL) as an adjunct to suturing for corneal perforation repair in rabbits.
Methods: A 4.5 mm corneal wound was created in New Zealand White Rabbits (right eyes), followed by suturing and RB-PCL treatment using 532 nm green light (0.6 W/cm²) and 0.01% RB photosensitizer. A control group received sutures alone. Healing was evaluated at Weeks 1, 2, and 4 using slit-lamp biomicroscopy, anterior segment optical coherence tomography (AS-OCT), RT-PCR for α-SMA gene expression, and immunofluorescence for myofibroblast activation. Histopathological changes were assessed via Hematoxylin and Eosin (H&E) staining, and corneal endothelial cell counts were taken to assess cytotoxicity.
Results: RB-PCL accelerated suture removal by Day 5, while sutures in the control group required longer retention. At Weeks 1 and 2, RB-PCL demonstrated lower inflammation and reduced corneal opacity. By Weeks 2 and 4, α-SMA expression was significantly reduced in the RB-PCL group, indicating reduced myofibroblast activation and fibrosis. H&E staining showed complete healing in the RB-PCL group by Week 2, whereas the control group had incomplete repair. By Week 4, the RB-PCL group had better fiber arrangement, while the control group showed persistent fibrosis. Immunofluorescence confirmed reduced α-SMA expression in the RB-PCL group. No retinal damage was observed, and endothelial cell counts were similar between groups, indicating RB-PCL's tolerability.
Conclusions: RB-PCL improved corneal wound healing, reduced fibrosis and opacity, and allowed earlier suture removal without phototoxicity. These results suggest RB-PCL is a promising adjunct for corneal perforation repair, enhancing both efficacy and tolerability.
期刊介绍:
Lasers in Surgery and Medicine publishes the highest quality research and clinical manuscripts in areas relating to the use of lasers in medicine and biology. The journal publishes basic and clinical studies on the therapeutic and diagnostic use of lasers in all the surgical and medical specialties. Contributions regarding clinical trials, new therapeutic techniques or instrumentation, laser biophysics and bioengineering, photobiology and photochemistry, outcomes research, cost-effectiveness, and other aspects of biomedicine are welcome. Using a process of rigorous yet rapid review of submitted manuscripts, findings of high scientific and medical interest are published with a minimum delay.